What are the regulatory requirements for herbal extracts for personal care

What are the regulatory requirements for herbal extracts for personal care

As the personal care industry continues its shift toward natural and plant-based ingredients, understanding the regulatory landscape for herbal extracts has become essential for manufacturers, formulators, and brand owners. Navigating these requirements correctly ensures product safety, market access, and consumer trust. This article provides a practical overview of the key regulatory frameworks governing herbal extracts for personal care across major global markets.

Why Regulation Matters for Herbal Extracts in Personal Care

Herbal extracts occupy a unique position in the personal care sector. They are neither fully cosmetic ingredients in the traditional sense nor are they pharmaceuticals. Depending on the claims made about a product and the concentration of active compounds, a formulation containing herbal extracts may be classified as a cosmetic, a cosmeceutical, or even an over-the-counter drug. This classification directly determines which regulatory pathway applies.

For botanical extract manufacturers and their clients, compliance is not optional. A single regulatory misstep can lead to product recalls, import rejections, or market bans. Understanding the requirements before sourcing ingredients is therefore a critical step in product development.

Key Regulatory Frameworks by Region

European union: EC 1223/2009 and ISO 16128

The EU maintains one of the most comprehensive regulatory systems for cosmetic products. Regulation EC 1223/2009 is the cornerstone legislation, requiring that every cosmetic product placed on the EU market has a designated Responsible Person, undergoes a safety assessment by a qualified professional, and maintains a Product Information File (PIF).

For herbal extracts specifically, the regulation mandates that all ingredients comply with the restrictions laid out in its annexes. Substances classified as CMR (carcinogenic, mutagenic, or toxic for reproduction) are generally prohibited. Additionally, ISO 16128 provides guidelines for determining the natural and organic content of cosmetic ingredients, which has become increasingly important for brands making natural claims.

The Nagoya Protocol on access to genetic resources and benefit-sharing (ABS) also applies within the EU via Regulation (EU) No. 511/2014. Companies sourcing plant-based ingredients must exercise due diligence to ensure that the plant materials were accessed legally and that benefits are shared with the country of origin.

United States: FDA and MoCRA 2022

In the United States, the regulatory framework for cosmetics underwent significant change with the Modernization of Cosmetics Regulation Act (MoCRA) of 2022. Under MoCRA, cosmetic manufacturers and processors must now register their facilities with the FDA and list their products along with ingredient information. This represents a major shift from the previous system, which largely relied on voluntary registration.

Herbal extracts used in personal care products fall under FDA oversight, but the classification depends on the product's intended use. If a product makes therapeutic claims (e.g., "treats eczema" or "reduces inflammation"), it may be regulated as a drug rather than a cosmetic. The Cosmetic Ingredient Review (CIR) panel regularly publishes safety assessments of botanical ingredients, and these assessments serve as important industry references even though they are not legally binding.

China: NMPA and IECIC

China has developed an ingredient-centric regulatory system through the National Medical Products Administration (NMPA). The Inventory of Existing Cosmetic Ingredients in China (IECIC) serves as the definitive list of permitted cosmetic ingredients. Any plant extract not listed in the IECIC must undergo a new cosmetic ingredient registration process before it can be used in products sold in China.

China also requires mandatory animal testing for certain cosmetic products under specific circumstances, though the regulations have been evolving. For botanical extracts for personal care entering the Chinese market, compliance with both the IECIC listing and the NMPA's technical standards for plant-derived ingredients is essential.

Other Key Markets: ASEAN, Japan, and South Korea

The ASEAN Cosmetic Directive harmonizes cosmetic regulations across ten Southeast Asian countries, requiring product notification and adherence to the ASEAN Cosmetic Ingredient Annexes. Japan regulates cosmetics under the Pharmaceutical and Medical Device Act, distinguishing between cosmetics and quasi-drugs based on active ingredient concentrations. South Korea's Ministry of Food and Drug Safety (MFDS) maintains a similarly structured system with its own approved ingredient lists and functional cosmetic categories.

Quality and Safety Standards for Herbal Extracts

Beyond regional regulations, several international standards govern the quality of herbal extracts used in personal care:

StandardScope
ISO 16128Guidelines for natural and organic cosmetic ingredients
GMP (Good Manufacturing Practice)Ensures consistent production quality and traceability
ISO 22716Cosmetics GMP guidelines covering production, control, storage, and shipment
HACCPHazard analysis and critical control points for ingredient safety
Halal & Kosher CertificationReligious compliance requirements for specific markets

Reputable botanical extract manufacturers typically provide comprehensive documentation including Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), and technical data sheets for each batch of extract. Third-party testing for heavy metals, pesticides, microbial contamination, and active compound standardization is standard practice for ingredients destined for the personal care market.

What to Look for in a Botanical Extract Supplier

When sourcing herbal extracts for personal care formulations, evaluating your supplier's regulatory readiness is as important as assessing product quality. Key considerations include:

  • Traceability: Can the supplier trace raw materials back to their geographic origin and provide documentation of legal access under the Nagoya Protocol?
  • Standardization: Does the extract come with a guaranteed percentage of active compounds, verified by HPLC or other analytical methods?
  • Documentation: Is a complete regulatory dossier available, including CoA, MSDS, stability data, and allergen statements?
  • Certifications: Does the supplier hold relevant certifications such as ISO, GMP, organic, Halal, or Kosher?
  • Regulatory Knowledge: Can the supplier provide guidance on which markets their ingredients are approved for and what documentation is needed for registration?

Pro Tip: When evaluating a supplier's compliance capability, ask for documentation specific to your target market. A supplier experienced in the EU market may not automatically have the paperwork required for China's IECIC or the FDA's MoCRA facility registration. Always verify market-specific readiness before committing to a supply agreement.

Conclusion

The regulatory landscape for herbal extracts in personal care is complex and varies significantly across regions. The EU's EC 1223/2009, the US FDA under MoCRA, and China's NMPA/IECIC system each impose distinct requirements that affect how plant-based ingredients can be sourced, tested, and marketed.

Success in this space depends on partnering with knowledgeable botanical extract manufacturers who understand these regulatory pathways and can provide the documentation and quality assurance that formulators need. By prioritizing regulatory compliance from the ingredient sourcing stage, personal care brands can avoid costly delays and bring safe, effective, and compliant products to market with confidence.